The degrees of spread to the medial and lateral pectoral, long thoracic, and thoracodorsal nerves were comparable between the groups.
Finally, since so many sites have adopted SCALE-UP at different times over the past two decades, we can examine sites at different implementation stages and ones that have achieved different degrees of spread within the universities.
High degrees of spread were noted among all correlations.
There were different degrees of spread in heritabilities, ranging from equal values for all traits (A, I, M and R) to sets of values which spanned a length interval of 0.80 (E, H, and O) and sets with a very uneven distribution of heritabilities (G, H, L, U and V).
However, while incidence by localised cancer in Aboriginal people is somewhat lower (non-significantly), and is non-significantly higher for cancer of unknown degree of spread, Aboriginal mortality from localised and unknown degree-of-spread cancers is significantly higher.
Degree-of-spread is assigned by the NSW CCR into one of four summary stages (localised, regional, distant or unknown) [ 25].
Further, the only measure of disease severity available was degree-of-spread at diagnosis; there were no indicators of performance status available.
# Adjusted for age-group, gender, histology, country of birth, degree-of-spread, tumour location, hospital admitted, area of service, Charlson comorbidity index, surgery type.
# Adjusted for age-group, gender, histology, country of birth, histology, degree-of-spread, tumour location, hospital admitted, area of service, Charlson comorbidity index.
The registry is managed according to the International Association of Cancer Registries (IACR) rules [ 32] and is one of the few Australian Cancer Registries to record degree-of-spread at first diagnosis for all solid malignant tumours [ 33].
For regional degree-of-spread cancers, these ratios are 0.32 versus 0.17 in males, and 0.25 versus 0.14 in females; for metastatic cancer the M I ratios are 0.49 versus 0.28 in males, and 0.32 versus 0.19 in females; and for cancer of unknown origin the M I ratios are 0.52 versus 0.32 in males and 0.25 versus 0.16.
